Literature DB >> 2416677

A role for self-recognizing T cells in the regulation of antibody-forming and cell-mediated cytotoxic responses in the mouse.

R M Gorczynski, M Boulanger.   

Abstract

Mitogen- or antigen-activated murine spleen and thymus cell blasts have been used as inducer cells to stimulate production of suppressor T cells (Ts) in autologous mixed leucocyte culture. Ts cells were induced in an MHC-restricted fashion and produced suppression of cell-mediated lympholysis and antibody synthesis from fresh spleen cells sharing MHC haplotypes with the Ts pool. Ts were Thy 1+, Lyt 1+ cells. Induction of Ts depended upon expression of class II MHC antigens on stimulating cells, but the level of Ts induced by different populations of suppressor inducer cells was not correlated with the level of Ia antigen expression. Activity of suppressor inducer cells was correlated with the functional activity of the inducer pool. The data are interpreted to favour a model in which Ts are induced by associative recognition on stimulator cells of class II MHC antigens and lymphocyte recognition receptors as nominal antigen (i.e. Ts are auto anti-idiotypic in nature). Using as stimulator/responder cells in AMLR lymphocytes taken from normal (8-week) or aged (greater than 24-month) mice, data were obtained consistent with this model and with earlier evidence for an altered expression of both lymphocyte recognition receptors and/or class II antigens in senescence.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416677      PMCID: PMC1453750     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  46 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

3.  Cloned human T lymphocytes with lymphostimulatory capacity preferentially activate suppressor cells.

Authors:  G Pawelec; E M Schneider; P Wernet
Journal:  Eur J Immunol       Date:  1984-04       Impact factor: 5.532

4.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

5.  Altered lymphocyte recognition repertoire during ageing. III. Changes in MHC restriction patterns in parental T lymphocytes and diminution in T suppressor function.

Authors:  R M Gorczynski; M Kennedy; S MacRae
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

6.  Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction.

Authors:  P L Romain; C Morimoto; J F Daley; L S Palley; E L Reinherz; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1984-01

7.  Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells.

Authors:  C A Janeway; P J Conrad; E A Lerner; J Babich; P Wettstein; D B Murphy
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

8.  Altered tumor growth in vivo after immunization of mice with antitumor antibodies.

Authors:  R M Gorczynski; M Kennedy; I Polidoulis; G B Price
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

9.  Studies on the syngeneic mixed lymphocyte reaction. III. Development of a monoclonal antibody with specificity for autoreactive T cells.

Authors:  P B Hausman; C E Moody; J B Innes; J J Gibbons; M E Weksler
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Peptide variability exists within alpha and beta subunits of the T cell receptor for antigen.

Authors:  O Acuto; S C Meuer; J C Hodgdon; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.